Viewing Study NCT00625456


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-01-01 @ 4:36 AM
Study NCT ID: NCT00625456
Status: COMPLETED
Last Update Posted: 2015-12-03
First Post: 2008-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors
Sponsor: Jennerex Biotherapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Lung Cancer View
None Renal Cell Carcinoma View
None Squamous Cell Carcinoma of the Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None phase I View
None advanced metastatic solid tumors View
None oncolytic virus View
None vaccinia virus View
None melanoma View
None lung cancer View
None renal cell carcinoma View
None squamous cell carcinoma of the head and neck View
None Pexa-Vec View